Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Manufactured in an FDA Registered Facility using Good Manufacturing Practices (GMPs) **This statement has not been evaluated by the Food and Drug Administration
For semaglutide, Novo Nordisk filed the composition patent in December 2003 (issued as US 8,927,488 in 2015), giving a base expiration of December 2023
Providers may request recent lab results from the last 12 months at their discretion
Market Positioning and Category Language The term "most effective peptide" appears within competitive market positioning language referenced in ProHealth's materials
US$ 29.24
US$ 29.38
US$ 28.42
US$ 20.46
